Zobrazeno 1 - 10
of 182
pro vyhledávání: '"Yu‐Feng Wei"'
Autor:
Yu-Ting Lai, Ying-Huang Tsai, Meng-Jer Hsieh, Ning-Hung Chen, Shih-Lung Cheng, Chi-Wei Tao, Yu-Feng Wei, Yao-Kuang Wu, Ming-Cheng Chan, Shih-Feng Liu, Wu-Huei Hsu, Tsung-Ming Yang, Ching-Lung Liu, Ping-Hung Kuo, Ming-Shian Lin
Publikováno v:
Respiratory Research, Vol 25, Iss 1, Pp 1-11 (2024)
Abstract Background Dual bronchodilator therapy, consisting of a long-acting beta-agonist (LABA) and a long-acting muscarinic antagonist (LAMA), has proven effective for patients with chronic obstructive pulmonary disease (COPD). However, it remains
Externí odkaz:
https://doaj.org/article/a9aacdd6fd0045f989dfd5a00202fa81
Autor:
Wen-Chien Cheng, Chia-Ling Chang, Chau-Chyun Sheu, Ping-Huai Wang, Meng-heng Hsieh, Ming-Tsung Chen, Wei-Fan Ou, Yu-Feng Wei, Tsung-Ming Yang, Chou-Chin Lan, Cheng-Yi Wang, Chih-Bin Lin, Ming-Shian Lin, Yao-Tung Wang, Ching-Hsiung Lin, Shih-Feng Liu, Meng-Hsuan Cheng, Yen-Fu Chen, Chung-Kan Peng, Ming-Cheng Chan, Ching-Yi Chen, Lun-Yu Jao, Ya-Hui Wang, Chi-Jui Chen, Shih-Pin Chen, Yi-Hsuan Tsai, Shih-Lung Cheng, Horng-Chyuan Lin, Jung-Yien Chien, Hao-Chien Wang, Wu-Huei Hsu, Taiwan Bronchiectasis Research Collaboration (TBARC)
Publikováno v:
European Journal of Medical Research, Vol 29, Iss 1, Pp 1-9 (2024)
Abstract Background Our study aimed to confirm a simplified radiological scoring system, derived from a modified Reiff score, to evaluate its relationship with clinical symptoms and predictive outcomes in Taiwanese patients with noncystic fibrosis br
Externí odkaz:
https://doaj.org/article/d6fb34231efd4744bcabce9248561dcc
Autor:
Yuan-Ting Hsu, Chao-Chien Wu, Chin-Chou Wang, Chau-Chyun Sheu, Yi-Hsin Yang, Ming-Yen Cheng, Ruay-Sheng Lai, Sum-Yee Leung, Chi-Cheng Lin, Yu-Feng Wei, Yung-Fa Lai, Meng-Hsuan Cheng, Huang-Chi Chen, Chih-Jen Yang, Chien-Jen Wang, Huei-Ju Liu, Hua-Ling Chen, Chih-Hsing Hung, Chon-Lin Lee, Ming-Shyan Huang, Shau-Ku Huang
Publikováno v:
Respiratory Research, Vol 25, Iss 1, Pp 1-16 (2024)
Abstract Background DEHP, a common plasticizer known for its hormone-disrupting properties, has been associated with asthma. However, a significant proportion of adult asthma cases are “non-atopic”, lacking a clear etiology. Methods In a case-con
Externí odkaz:
https://doaj.org/article/34bd386c636441e7b1454e7182b61fd4
Autor:
Jung-Yueh Chen, Sheng-Kai Liang, Tzu-Yi Chuang, Chia-Yu Chu, Chia-Hung Tu, Yu-Jo Yeh, Yu-Feng Wei, Kuan-Yu Chen
Publikováno v:
Journal of the Formosan Medical Association, Vol 123, Iss 2, Pp 198-207 (2024)
Background: Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are used as the standard first-line treatment for patients with advanced EGFR-mutated non-small cell lung cancer (NSCLC). However, the impact of comorbidities and tre
Externí odkaz:
https://doaj.org/article/35cd2d64adf249559b93739c6530ae0d
Publikováno v:
Journal of Microbiology, Immunology and Infection, Vol 57, Iss 1, Pp 164-174 (2024)
Purpose: The treatment advantage of guideline-based therapy (GBT) in Mycobacterium avium complex lung disease (MAC-LD) is well-known. However, GBT is not always feasible. The aim of the study was to analyze the relationship of treatment regimens and
Externí odkaz:
https://doaj.org/article/672dff860d1740bb9feeca63ede6723b
Autor:
Chao-Hsien Chen, Cheng-Yi Wang, Ching-Yi Chen, Ya-Hui Wang, Kuang-Hung Chen, Chih-Cheng Lai, Yu-Feng Wei, Pin-Kuei Fu
Publikováno v:
PLoS ONE, Vol 19, Iss 1, p e0295366 (2024)
The influence of inhaled corticosteroids (ICS) on COVID-19 outcomes remains uncertain. To address this, we conducted a systematic review and meta-analysis, analyzing 30 studies, to investigate the impact of ICS on patients with COVID-19. Our study fo
Externí odkaz:
https://doaj.org/article/655a7a22f77c4e1d89e48487c40d64a7
Autor:
Chao-Hsien Chen, Ching-Yi Chen, Chih-Cheng Lai, Ya-Hui Wang, Kuang-Hung Chen, Cheng-Yi Wang, Yu-Feng Wei, Pin-Kuei Fu
Publikováno v:
Journal of Infection and Public Health, Vol 16, Iss 5, Pp 823-830 (2023)
Background: The effect of inhaled corticosteroid (ICS) on the risk of severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infection is unclear. Methods: We performed a systematic review and meta-analysis of clinical studies that assessed the
Externí odkaz:
https://doaj.org/article/2cbf9ba44f364d9db3af54c2e3e05b01
Autor:
Cheng-Yu Chang, Yu-Feng Wei, Chung-Yu Chen, Yi-Chun Lai, Po-Wei Hu, Jui-Chi Hung, Chi-Hsiang Chu, Hsin-Tzu Chuang, Shih-Chieh Chang
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
IntroductionRandomized controlled trials have demonstrated a reduction in the decline of lung function and a reduced risk of acute exacerbation in patients with idiopathic pulmonary fibrosis treated with the antifibrotic prifenidone. The present stud
Externí odkaz:
https://doaj.org/article/526152761fbc4431bc763f4048d331fb
Autor:
Cheng-Yu Chang, Chung-Yu Chen, Shih-Chieh Chang, Ching-Yi Chen, Yi-Chun Lai, Chun-Fu Chang, Yu-Feng Wei
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
PurposeEpidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are standard first-line treatments for advanced EGFR-mutant non-small-cell lung cancer (NSCLC) patients. However, factors associated with outcomes after progression on fir
Externí odkaz:
https://doaj.org/article/cc725836f1ea450cad1180c1b6ccc8d3
Autor:
Chao-Chun Chang, En-Kuei Tang, Yu-Feng Wei, Chia-Ying Lin, Fu-Zong Wu, Ming-Ting Wu, Yi-Sheng Liu, Yi-Ting Yen, Mi-Chia Ma, Yau-Lin Tseng
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Externí odkaz:
https://doaj.org/article/22166e61307c46e2ab6a440311c156bc